Liver and biliary tract disorders in pregnancy, third trimester
ICD-10 O26.613 is a billable code used to indicate a diagnosis of liver and biliary tract disorders in pregnancy, third trimester.
Liver and biliary tract disorders during the third trimester of pregnancy can present significant challenges for maternal and fetal health. Conditions such as intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, and hepatitis can complicate the pregnancy, leading to increased risks for both the mother and the fetus. Symptoms may include jaundice, pruritus, abdominal pain, and elevated liver enzymes. Management often requires a multidisciplinary approach, including obstetricians, maternal-fetal medicine specialists, and hepatologists. Close monitoring of liver function tests and fetal well-being is essential. The timing of delivery may be influenced by the severity of the liver disorder, with early delivery considered in cases of severe cholestasis or acute fatty liver to prevent complications such as fetal distress or stillbirth. Proper documentation of the condition, its severity, and the management plan is crucial for accurate coding and reimbursement.
Detailed documentation of maternal symptoms, liver function tests, and management strategies.
Management of a pregnant patient presenting with jaundice and elevated liver enzymes.
Consideration of fetal monitoring and potential early delivery based on maternal liver health.
Comprehensive documentation of high-risk factors, including maternal history and current liver function.
Assessment of fetal well-being in a patient with intrahepatic cholestasis.
Focus on the implications of liver disorders on fetal outcomes and the need for specialized care.
Used for initial evaluation of a pregnant patient with liver dysfunction.
Document history, physical examination, and any lab results.
Obstetricians should ensure that all relevant symptoms and lab findings are included.
Common liver disorders in pregnancy include intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, and hepatitis. Each condition has specific management protocols and implications for both maternal and fetal health.
